KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Working Capital Changes (2016 - 2020)

Historic Other Working Capital Changes for Thermo Fisher Scientific (TMO) over the last 12 years, with Q4 2020 value amounting to -$410.0 million.

  • Thermo Fisher Scientific's Other Working Capital Changes fell 32282.61% to -$410.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.5 billion, marking a year-over-year decrease of 83333.33%. This contributed to the annual value of $186.0 million for FY2024, which is 7680.8% down from last year.
  • According to the latest figures from Q4 2020, Thermo Fisher Scientific's Other Working Capital Changes is -$410.0 million, which was down 32282.61% from -$739.0 million recorded in Q3 2020.
  • Over the past 5 years, Thermo Fisher Scientific's Other Working Capital Changes peaked at $443.0 million during Q1 2020, and registered a low of -$746.0 million during Q2 2020.
  • Its 5-year average for Other Working Capital Changes is -$48.0 million, with a median of $45.4 million in 2016.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 69710.14% in 2017, then plummeted by 98545.45% in 2019.
  • Over the past 5 years, Thermo Fisher Scientific's Other Working Capital Changes (Quarter) stood at $60.7 million in 2016, then crashed by 231.8% to -$80.0 million in 2017, then plummeted by 146.25% to -$197.0 million in 2018, then soared by 193.4% to $184.0 million in 2019, then plummeted by 322.83% to -$410.0 million in 2020.
  • Its Other Working Capital Changes stands at -$410.0 million for Q4 2020, versus -$739.0 million for Q3 2020 and -$746.0 million for Q2 2020.